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Background:  
Population immune profile for influenza is highly affected by circulating influenza viruses, thus changing the risk of infection for influenza. This study aim was to 
assess influenza immunity in the Portuguese population by age groups, during 2014 and 2015 and establish a relationship between seroprotection and 
circulating influenza viruses in 2014/15 and 2015/16 seasons. 
Conclusions:  
 There was a correlation between virus circulation, incidence rates for each age group and the previous seroprotection for seasonal influenza 
viruses. Our study highlights the value of measuring the serological profile for influenza to establish risk groups for infection for which an  
increase preventive measures, including vaccination, should be fostered.   
Portuguese Laboratory Network for the Diagnosis of Influenza Infection 
Influenza seroprotection correlates with 
predominant circulating viruses during  
2014/15 and 2015/16 seasons in Portugal  
Table I – Seroprevalence (HI titre ≥ 40) for influenza A(H1)pdm09, A(H3), B/Yamagata and B/Victoria viruses during 2014 and 2015. (2014 n=626; 2015 n=675). 
Antigens used in  2014a and 2015b study:  
a A/California/7/2009; A/Texas/50/2012;  B/Massachusetts/2/2012 (Yamagata lineage); B/Brisbane/60/2008 (Victoria lineage). 
b A/California/7/2009; A/Switzerland/9715293/2013; B/Phuket/3073/2013 (Yamagata lineage); B/Brisbane/60/2008 (Victoria lineage).  
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Methods:   
Two cross-sectional studies were developed based on a convenience serum sample collected in June 2014 (n=626) and July 2015 (n=675) in hospitals from 
Portugal mainland, Azores and Madeira. Serums equally represent all age groups. Antibody titers were evaluated by HI assay for strains recommended for 
seasonal influenza vaccine northern hemisphere, 2014/15 and 2015/2016. Seroprevalences were estimated for each strain by age group and the association 
with seasonal cumulative influenza-like illness (ILI) rates for influenza virus during both seasons was analyzed.   
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Influenza Seroprevalence (HI ≥ 40) 
2014a 2015b 
n % 95%CI n % 95%CI 
A(H1)pdm09 186 30 26-33 209 31 26-34 
A(H3) 250 40 26-44 262 39 35-43 
B Yamagata 144 23 20-26 372 55 51-59 
B Victoria 57 9 7-12 147 22 19-25 
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Results:  
2014 
- The highest seroprotection was observed for influenza 
A(H3) (40%) and A(H1)pdm09 (30%), with higher levels in 
children 5-14 years old (Table I, Figure 2);  
 
- During 2014/2015 influenza B/Yamagata was dominant with 
high incidence rates in individuals under 65 years old, the 
ones that had lower seroprotection in 2014 (Figure 1 and 2); 
 
- Although high protection for A(H3), the circulation of the 
new drift A(H3) strains had gained an immunological 
advantage, with A(H3) elevated incidence rates observed 
during 2014/15 (Figure 2). 
 
2015 
- The highest seroprotection was observed for influenza  
B/ Yamagata (55%), 2.4 times the estimated in 2014. Being 
in younger's (≤ 4 years old), 6.3 times higher in 2015, in 
agreement with high ILI incidence rate in children during 
2014/2015 epidemic (Table I, Figure 2);   
 
- Seroprotection levels for influenza A(H1)pdm09 and A(H3) 
were not significantly different from 2014 (Table I, Figure 2);  
 
- The lowest level of seroprotection was observed for 
B/Victoria lineage (22%) in the general population before the 
start of 2015/2016 season (Table I);  
 
-Influenza A(H1N1)pdm09 was predominant, with high 
incidence rate in < 65 year old (Figure 2).  
Figure  1 – Influenza virus type/subtype detected in circulation during 2014/2015 and 
2015/2016 seasons in Portugal.   
Figure  2 – Seroprevalence for influenza A(H1)pdm09, A(H3), B/Yamagata and B/Victoria viruses by age group during 2014 and 2015.  
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